vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and MERCURY GENERAL CORP (MCY). Click either name above to swap in a different company.
MERCURY GENERAL CORP is the larger business by last-quarter revenue ($1.5B vs $950.5M, roughly 1.6× Astrana Health, Inc.). MERCURY GENERAL CORP runs the higher net margin — 13.2% vs 0.7%, a 12.5% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 12.4%). MERCURY GENERAL CORP produced more free cash flow last quarter ($273.9M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 9.8%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Mercury General Corporation is a multiple-line insurance organization that offers personal automobiles, homeowners, renters, and business insurance. Mercury's primary focus is automobiles and homeowners' insurance.
ASTH vs MCY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.5B |
| Net Profit | $6.6M | $202.5M |
| Gross Margin | — | 99.7% |
| Operating Margin | 1.9% | 16.2% |
| Net Margin | 0.7% | 13.2% |
| Revenue YoY | 42.9% | 12.4% |
| Net Profit YoY | 184.4% | 100.4% |
| EPS (diluted) | $0.12 | $3.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.5B | ||
| Q3 25 | $956.0M | $1.6B | ||
| Q2 25 | $654.8M | $1.5B | ||
| Q1 25 | $620.4M | $1.4B | ||
| Q4 24 | $665.2M | $1.4B | ||
| Q3 24 | $478.7M | $1.5B | ||
| Q2 24 | $486.3M | $1.3B | ||
| Q1 24 | $404.4M | $1.3B |
| Q4 25 | $6.6M | $202.5M | ||
| Q3 25 | $373.0K | $280.4M | ||
| Q2 25 | $9.4M | $166.5M | ||
| Q1 25 | $6.7M | $-108.3M | ||
| Q4 24 | $-7.8M | $101.1M | ||
| Q3 24 | $16.1M | $230.9M | ||
| Q2 24 | $19.2M | $62.6M | ||
| Q1 24 | $14.8M | $73.5M |
| Q4 25 | — | 99.7% | ||
| Q3 25 | — | 99.8% | ||
| Q2 25 | — | 99.8% | ||
| Q1 25 | — | 99.7% | ||
| Q4 24 | — | 99.7% | ||
| Q3 24 | — | 99.8% | ||
| Q2 24 | — | 99.8% | ||
| Q1 24 | — | 99.7% |
| Q4 25 | 1.9% | 16.2% | ||
| Q3 25 | 2.0% | 22.1% | ||
| Q2 25 | 3.1% | 14.0% | ||
| Q1 25 | 3.3% | -10.2% | ||
| Q4 24 | 0.1% | 9.0% | ||
| Q3 24 | 5.9% | 18.8% | ||
| Q2 24 | 6.2% | 5.8% | ||
| Q1 24 | 7.5% | 7.0% |
| Q4 25 | 0.7% | 13.2% | ||
| Q3 25 | 0.0% | 17.7% | ||
| Q2 25 | 1.4% | 11.3% | ||
| Q1 25 | 1.1% | -7.8% | ||
| Q4 24 | -1.2% | 7.4% | ||
| Q3 24 | 3.4% | 15.1% | ||
| Q2 24 | 3.9% | 4.8% | ||
| Q1 24 | 3.7% | 5.8% |
| Q4 25 | $0.12 | $3.66 | ||
| Q3 25 | $0.01 | $5.06 | ||
| Q2 25 | $0.19 | $3.01 | ||
| Q1 25 | $0.14 | $-1.96 | ||
| Q4 24 | $-0.14 | $1.82 | ||
| Q3 24 | $0.33 | $4.17 | ||
| Q2 24 | $0.40 | $1.13 | ||
| Q1 24 | $0.31 | $1.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | — |
| Total DebtLower is stronger | — | $575.0M |
| Stockholders' EquityBook value | $779.3M | $2.4B |
| Total Assets | $2.2B | $9.6B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | — | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | — | ||
| Q1 24 | $337.3M | — |
| Q4 25 | — | $575.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $575.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $779.3M | $2.4B | ||
| Q3 25 | $775.5M | $2.2B | ||
| Q2 25 | $765.5M | $2.0B | ||
| Q1 25 | $745.4M | $1.8B | ||
| Q4 24 | $712.7M | $1.9B | ||
| Q3 24 | $704.6M | $1.9B | ||
| Q2 24 | $678.9M | $1.6B | ||
| Q1 24 | $653.5M | $1.6B |
| Q4 25 | $2.2B | $9.6B | ||
| Q3 25 | $2.2B | $9.4B | ||
| Q2 25 | $1.4B | $9.1B | ||
| Q1 25 | $1.3B | $9.0B | ||
| Q4 24 | $1.4B | $8.3B | ||
| Q3 24 | $1.3B | $8.2B | ||
| Q2 24 | $1.3B | $7.7B | ||
| Q1 24 | $1.2B | $7.4B |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $287.9M |
| Free Cash FlowOCF − Capex | $-6.0M | $273.9M |
| FCF MarginFCF / Revenue | -0.6% | 17.8% |
| Capex IntensityCapex / Revenue | 0.3% | 0.9% |
| Cash ConversionOCF / Net Profit | -0.44× | 1.42× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $1.0B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $287.9M | ||
| Q3 25 | $10.0M | $496.4M | ||
| Q2 25 | $90.9M | $371.6M | ||
| Q1 25 | $16.6M | $-68.7M | ||
| Q4 24 | $-10.9M | $248.3M | ||
| Q3 24 | $34.0M | $318.1M | ||
| Q2 24 | $23.2M | $278.0M | ||
| Q1 24 | $6.0M | $192.6M |
| Q4 25 | $-6.0M | $273.9M | ||
| Q3 25 | $7.4M | $479.5M | ||
| Q2 25 | $89.5M | $357.2M | ||
| Q1 25 | $13.6M | $-81.9M | ||
| Q4 24 | $-13.5M | $236.0M | ||
| Q3 24 | $31.7M | $306.2M | ||
| Q2 24 | $20.4M | $266.5M | ||
| Q1 24 | $5.6M | $182.4M |
| Q4 25 | -0.6% | 17.8% | ||
| Q3 25 | 0.8% | 30.3% | ||
| Q2 25 | 13.7% | 24.2% | ||
| Q1 25 | 2.2% | -5.9% | ||
| Q4 24 | -2.0% | 17.3% | ||
| Q3 24 | 6.6% | 20.0% | ||
| Q2 24 | 4.2% | 20.4% | ||
| Q1 24 | 1.4% | 14.3% |
| Q4 25 | 0.3% | 0.9% | ||
| Q3 25 | 0.3% | 1.1% | ||
| Q2 25 | 0.2% | 1.0% | ||
| Q1 25 | 0.5% | 0.9% | ||
| Q4 24 | 0.4% | 0.9% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 0.6% | 0.9% | ||
| Q1 24 | 0.1% | 0.8% |
| Q4 25 | -0.44× | 1.42× | ||
| Q3 25 | 26.69× | 1.77× | ||
| Q2 25 | 9.65× | 2.23× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | 2.46× | ||
| Q3 24 | 2.11× | 1.38× | ||
| Q2 24 | 1.21× | 4.44× | ||
| Q1 24 | 0.40× | 2.62× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
MCY
Segment breakdown not available.
